George Scangos' Bold Vision Post author:Sam Post published:October 24, 2017 Post category:BioPharma The former Biogen CEO is making waves at his new venture, Vir Biotechnology. Source: BioSpace You Might Also Like Blue Earth Diagnostics Receives Positive Opinion For Axumin (Fluciclovine (18F)) For PET Imaging Of Recurrent Prostate Cancer March 23, 2017 Ex-Genentech Employees' Denali Breaks 2017 IPO Records, Raises $250M December 7, 2017 Investors May be Overlooking This Small, Fast-Growing Bay Area Biotech October 24, 2017
Blue Earth Diagnostics Receives Positive Opinion For Axumin (Fluciclovine (18F)) For PET Imaging Of Recurrent Prostate Cancer March 23, 2017
